A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

March 31, 2021

Conditions
Acute Ischemic Stroke
Interventions
DRUG

LT3001 Drug Product

Active comparator

DRUG

Placebo

Placebo comparator

Trial Locations (10)

37403

RECRUITING

Chattanooga Center for Neurologic Research, Chattanooga

40536

RECRUITING

University of Kentucky Chandler Medical Center, Lexington

43210

RECRUITING

The Ohio State University - Wexner Medical Center, Columbus

08837

RECRUITING

JFK Neuroscience Institute, JFK Medical Center, Edison

Unknown

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

RECRUITING

Linkou Chang Gung Memorial Hospital, New Taipei City

RECRUITING

Taipei Medical University - Shuang Ho Hospital, New Taipei City

RECRUITING

China Medical University Hospital, Taichung

RECRUITING

Taichung Veterans General Hospital, Taichung

RECRUITING

Taipei Veterans General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Lumosa Therapeutics Co., Ltd.

INDUSTRY